# Epigenetic Regulation of Higher-Order Chromatin Structure (HOCS) and Its Implication in Human Diseases

## TL;DR

This paper reviews how DNA's 3D structure is regulated by epigenetic mechanisms and how disruptions in this structure can lead to diseases like cancer.

## Contribution

The paper emphasizes the role of genomic regulatory hubs in chromatin architecture and their potential as biomarkers or therapeutic targets.

## Key findings

- Disruptions in chromatin structure contribute to cancer and other diseases through gene regulation changes.
- Architectural proteins and epigenetic modulators shape dynamic chromatin folding.
- Genomic regions regulating 3D genome dynamics are promising for precision medicine.

## Abstract

This review explores how DNA folds into 3D higher-order chromatin structures that regulate gene activity. It highlights how epigenetic mechanisms and architectural proteins work together to shape the dynamic chromatin folding while allowing structural flexibility based on cellular needs. Disruption of these folding patterns leads to aberrant gene regulation, contributing to cancer, aging-related disorders, and certain congenital conditions. We emphasize specific genomic regions and epigenetic modulators that act as regulatory hubs for 3D organization, which could serve as promising biomarkers or therapeutic targets for cancer. Overall, it underscores the importance of a deeper understanding of DNA’s large-scale 3D architecture for advancing precision medicine and developing novel diagnostic approaches for cancer and other human diseases.

Higher-order chromatin structures (HOCS) are fundamental to genome organization, gene regulation, and cellular homeostasis. This review examines the epigenetic mechanisms shaping HOCS, including DNA methylation, histone modifications, chromatin remodeling, and RNA-based regulatory processes. We also discuss the role of architectural proteins in maintaining chromatin topology while allowing dynamic changes to chromatin structure, thereby influencing gene expression. Growing evidence indicates that disruptions in HOCS contribute to a diverse array of human diseases, including cancer, aging-related disorders, and congenital abnormalities, primarily through aberrant gene regulation. We further discuss the concept of distinct genomic areas, in which specific chromatin regions orchestrate three-dimensional (3D) genome dynamics, positioning them as potential biomarkers and therapeutic targets. By emphasizing chromatin architecture on a global scale rather than at the level of individual genes, this review underscores its emerging relevance to precision medicine. Finally, we synthesize current technical advances, outline future directions for leveraging chromatin topology in disease diagnosis and treatment, and highlight key biological insights to reshape our understanding of genome function.